Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Europe
 More »

  • World Vaccine Congress Europe
    Lille FRANCE http://www.terrapinn.com/2013/world-vaccine-congress-europe
    10-16-2013
  • BASF Using Dyadic Technology for New Enzymes in $6M+ Deal
    portfolio of omega-3 fatty acids for the human nutrition and pharmaceutical industries, all during the trade shows Vitafoods Europe 2013 in Geneva and IFIA Japan 2013 in Tokyo. ...
    5-15-2013
  • Softening the Blow from FOLFOX Treatment
    Afterward, a total of 126 patients from at least 28 centers in Europe and the U.S. will be randomized for either PledOx in two different doses or placebo in the same manner. That ...
    5-15-2013
  • Induced Pluripotent Stem Cells: A U.S. Patent Landscape Analysis
    ... more iPSC patent filings (32) than all of Europe (16) and Asia outside of Japan (11). ... Within the rest of Europe, the strongest mini-cluster is found in Munich (not shown), with ...
    5-13-2013
  • Amgen Forms Joint Venture to Sell Vectibix in China
    Like other biopharmas, Amgen is counting on expanded indications and increased sales in China and other emerging markets to make up for sales to be lost in the U.S. and Europe due ...
    5-10-2013
  • Companion Diagnostics: 52 Pick-Up
    ... for patients with locally advanced or metastatic NSCLC, with an EGFR mutation detected by an FDA-approved test. In Europe, diagnostic is CE-marked and available for diagnostic use. ...
    5-9-2013
  • The Globalization of IVD Companies
    ... behind that of Latin America (9%), Eastern Europe (10%), and Asia-Pacific (12%) markets. ... strategy as these markets are outpacing IVD growth in the United States and Europe. ...
    5-1-2013
  • Comparative Genomics: Insights into Disease Susceptibility
    ... Currently, the software suite is being used in projects offering genomics services for clinical and pharmaceutical customers in Europe and the U.S. to interpret the extensive data ...
    5-1-2013
  • Enzon Gives Up Hope to Sell
    A long-term recovery is unlikely for Enzon, since its U.S. royalties on Merck sales of the drug end in 2016, followed by the end of royalties in Europe (2018) and Japan (2019). ...
    4-24-2013
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    ... Other highlights of Beyond Borders: VC investment dips: Venture capital funding across North America and Europe fell 5% in 2012, to $5.4 billion. The decline was slower than ...
    4-22-2013
  • Biosimilars: 10 Drugs to Watch
    different drug classes helps explain why Europe is much further along than the U.S. in ... Patents set to expire July 2014 in Europe, and June 2019 in the U.S. Humira ...
    4-22-2013
  • Biosearch Moving into New Digs for GMP Production
    Biosearch Technologies, a company that specializes in the development and manufacture of GMP-grade oligonucleotides, is moving its GMP manufacturing process into a new GMP ...
    4-18-2013
  • NanoString Nabs License to Liver Cancer Gene Signature
    signature was highly correlated with survival in a training set of 82 Japanese patients and was validated in an independent set of 225 patients from the United States and Europe. ...
    4-17-2013
  • Poland Invests in Biotech Infrastructure
    ... give us a superior position in the Polish market and a very strong position in Europe." ... Blirt explains: "As a service provider in Europe, we have become known as contract ...
    4-15-2013
  • Thermo Fisher Swallows Life Tech
    ... Asia-Pacific will account for 18% of revenues for the new Thermo Fisher, compared with North America (52%), Europe (26%), and the rest of the world (4%). "This is an important ...
    4-15-2013
  • More »

    Journal Articles

  • Molecular Detection of Anaplasma phagocytophilum in the European...
    Jasmin Skuballa, Trevor Petney, Miriam Pfäffle, Horst Taraschewski
    Vector-Borne and Zoonotic Diseases
    Abstract The European hedgehog (Erinaceus europaeus) is a common wild mammal in Central Europe that shares habitats with humans in urban, peri-urban, and rural areas. Thus, this ...
  • Hantaviruses and Their Hosts in Europe: Reservoirs Here and There...
    Gert E. Olsson, Herwig Leirs, Heikki Henttonen
    Vector-Borne and Zoonotic Diseases
    in Europe: Reservoirs Here and There, But Not Everywhere? Vector-Borne and Zoonotic Diseases Abstract Five hantaviruses are known to circulate among rodents in Europe, and at ...
  • First Molecular Detection of Anaplasma phagocytophilum in European...
    Bronislava Víchová, Viktória Majláthová, Mária Nováková, Martin Straka, Branislav Pet'ko
    Vector-Borne and Zoonotic Diseases
    First Molecular Detection of Anaplasma phagocytophilum in European Brown Bear ( Ursus arctos ) Vector-Borne and Zoonotic Diseases Abstract In Europe, Anaplasma phagocytophilum ...
  • Prevalence of Five Pathogenic Agents in Questing Ixodes ricinus...
    Violaine Cotté, Sarah Bonnet, Martine Cote, Muriel Vayssier-Taussat
    Vector-Borne and Zoonotic Diseases
    Vector-Borne and Zoonotic Diseases Abstract In Europe, Ixodes ricinus ticks are vectors of ... to Borrelia carolinensis, a newly described species never reported in Europe so far. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll